Recently, the Chemical Reprogramming Induced Human Pluripotent Stem Cell Technology Exchange Conference was held at2023year9moon7Day9moon20Day and9moon21The event was successfully held in Beijing, Shanghai, and Suzhou.This exchange conference attracted numerous experts, scholars, and students interested in somatic cell chemical reprogramming technology. Attend the meetingone whoThey all expressed their opinions，The meeting content is enriched、benefit a lot

In the first half of the technical exchange meeting, Dr. Zhu Jialiang first shared the research background, significance, and application cases of chemical reprogramming technology, and proposed that using chemical small molecules to regulate cell fate transformation has significant advantages in safety, ease of operation, and efficiency.

In the second half of the meeting, Dr. Liu Bei gave a specific explanation of the operation of chemical reprogramming technology, sharing in detail the key points and precautions in each stage of chemical reprogramming technology, laying a solid foundation for everyone to carry out related experiments in the future.

Each discussion sessionPassionate interaction，Show attendanceThe peopleRegarding thisThere is great attention and expectation for the new generation of somatic cell induction technology.

Chemical reprogramming is a new generation of human pluripotent stem cell preparation technology independently developed by Professor Deng Hongkui's team at Peking University, compared to traditional methodsThe preparation of pluripotent stem cells through "somatic cell nuclear transfer" and "transgenic overexpression transcription factor" reprogramming, with chemical reprogramming being simpler, more efficient, and safer, has solved the "bottleneck" problem in the underlying technology for the development of stem cells and regenerative medicine in China.

At present, this cutting-edge technology is authorized and transformed by Beijing Beiqi Biopharmaceutical Co., Ltd. Chemical reprogramming induces human pluripotent stem cells（CiPSC）In addition to preparing reagent kits, the company has also successfully developed research and clinical applicationsGMPGrade seed cells have officially begun commercial cooperation with external parties, such as applications in in in vitro drug screening, organoid differentiation, and clinical drug pipeline development.

In order to enable more researchers to understand this new technology and accelerate its application in scientific research and clinical treatment, Beiqi Biotechnology will continue to hold similar events nationwideFree technical exchange meetingPlease pay attention to Beiqi Biotechnology/Get more information about the meeting on Beijing Satek official account.

The registration channel for the Guangzhou station of the current technical exchange meeting has officially opened. For specific arrangements, please refer to the meeting schedule below. To register, please send an email containing your name, affiliation, and phone number toselina@cy-tech.com.cnWe will have colleagues confirm the specific registration details with you.

Welcome teachers and students who are interested in this technology to actively register and work together to promote the leapfrog development of China in the field of stem cells!